Exhaled markers of inflammation

被引:78
作者
Kharitonov, Sergei A. [1 ]
Barnes, Peter J. [1 ]
机构
[1] Imperial Coll, Natl Heart & Lung Inst, London, England
关键词
D O I
10.1097/01.all.0000011017.58506.f1
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Exhaled markers of inflammation allow completely noninvasive monitoring of inflammation and oxidative stress in the respiratory tract in inflammatory lung diseases, including asthma, chronic obstructive pulmonary disease, cystic fibrosis, bronchiectasis and interstitial lung diseases. Such noninvasive techniques are simple to perform, may be repeated frequently and can be applied in children, including neonates and patients with severe disease in whom more invasive procedures are not possible. Several volatile chemicals can be measured in the breath (nitric oxide, carbon monoxide, hydrocarbons), and many nonvolatile molecules (mediators, oxidation and nitration products, proteins) may be measured in exhaled breath condensate. (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 93 条
[1]  
Adisesh LA, 1998, CLIN EXP ALLERGY, V28, P876
[2]  
AGARKOV F T, 1984, Fiziologiya Cheloveka, V10, P981
[3]  
AGARKOV F T, 1970, Gigiena Truda i Professional'nye Zabolevaniya, V14, P31
[4]  
[Anonymous], 1999, Am J Respir Crit Care Med, V160, P2104
[5]   Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis [J].
Antuni, JD ;
Kharitonov, SA ;
Hughes, D ;
Hodson, ME ;
Barnes, PJ .
THORAX, 2000, 55 (02) :138-142
[6]   Differential anti-inflammatory effects of immunosuppressive drugs:: Cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production [J].
Attur, MG ;
Patel, R ;
Thakker, G ;
Vyas, P ;
Levartovsky, D ;
Patel, P ;
Naqvi, S ;
Raza, R ;
Patel, K ;
Abramson, D ;
Bruno, G ;
Abramson, SB ;
Amin, AR .
INFLAMMATION RESEARCH, 2000, 49 (01) :20-26
[7]   Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults [J].
Aziz, I ;
Wilson, AM ;
Lipworth, BJ .
CHEST, 2000, 118 (04) :1049-1058
[8]  
Balint B, 2000, AM J RESP CRIT CARE, V161, pA288
[9]  
Biernacki W, 1999, AM J RESP CRIT CARE, V159, pA631
[10]   NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast [J].
Bisgaard, H ;
Loland, L ;
Anhoj, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (04) :1227-1231